Levetiracetam dosing in patients receiving continuous renal replacement therapy-Reference-Cited by-同舟云学术

Levetiracetam dosing in patients receiving continuous renal replacement therapy

Published:2021-07-11 Issue:9 Volume:62 Page:2151-2158
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Chaijamorn Weerachai¹,Charoensareerat Taniya¹,Rungkitwattanakul Dhakrit²,Phunpon Sathian¹,Sathienluckana Thanompong¹,Srisawat Nattachai³⁴⁵⁶⁷,Pattharachayakul Sutthiporn⁸^ORCID

Affiliation:

1. Faculty of Pharmacy Siam University Bangkok Thailand

2. Department of Clinical and Administrative Pharmacy Sciences College of Pharmacy Howard University Washington DC USA

3. Division of Nephrology Department of Medicine Faculty of Medicine Chulalongkorn University, and King Chulalongkorn Memorial Hospital Bangkok Thailand

4. Excellence Center for Critical Care Nephrology King Chulalongkorn Memorial Hospital Bangkok Thailand

5. Critical Care Nephrology Research Unit Faculty of Medicine Chulalongkorn University Bangkok Thailand

6. Academic of Science Royal Society of Thailand Bangkok Thailand

7. Tropical Medicine Cluster Chulalongkorn University Bangkok Thailand

8. Department of Clinical Pharmacy Faculty of Pharmaceutical Sciences Prince of Songkla University Songkhla Thailand

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16971

Reference25 articles.

1. Levetiracetam: a review of its use in epilepsy;Lyseng‐Williamson KA;Drugs,2011

2. Safety and Efficacy of Levetiracetam for Critically Ill Patients with Seizures

3. Clinical Pharmacokinetics of Levetiracetam

4. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): Characterization by dynamic liver function tests

5. We Underdose Antibiotics in Patients on CRRT

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a physiologically based pharmacokinetic model for levetiracetam in patients with renal impairment to guide dose adjustment based on steady-state peak/trough concentrations;Xenobiotica;2024-02-21

2. Lacosamide dosing in patients receiving continuous renal replacement therapy;Journal of Intensive Care;2023-11-09

3. Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care – an overview;Expert Opinion on Drug Metabolism & Toxicology;2022-08-30